25-O-acetylcimigenol-3-O-beta-D-xylopyranoside: from Cimicifuga dahurica; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 91826996 |
| MeSH ID | M0493810 |
| Synonym |
|---|
| unii-915xs7t0os |
| 25-o-acetylcimigenol-3-o-beta-d-xylopyranoside |
| beta-d-xylopyranoside, (3beta,15alpha,16alpha,23r,24s)-25-(acetyloxy)-16,23:16,24-diepoxy-15-hydroxy-9,19-cyclolanostan-3-yl |
| 25-o-acetylcimigenol-3-o-beta-d-xyloside (24s) (constituent of black cohosh) [dsc] |
| 25-o-acetylcimigenol-3-o-.beta.-d-xyloside (24s) (constituent of black cohosh) [dsc] |
| 915XS7T0OS , |
| cimigenoside, 25-acetate |
| 25-o-acetylcimigenol-3-o-.beta.-d-xylopyranoside |
| .beta.-d-xylopyranoside, (3.beta.,15.alpha.,16.alpha.,23r,24s)-25-(acetyloxy)-16,23:16,24-diepoxy-15-hydroxy-9,19-cyclolanostan-3-yl |
| Q27271378 |
| CS-0634320 |
| HY-N10700 |
| 25-o-acetylcimigenol-3-o-beta-d-xyloside (24s) (constituent of black cohosh) |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||